DILI | Visikol

Visikol to present at SELECTBIO’s December 2021 Conference

Carol Tomaszewski2021-11-05T15:34:56-05:00

Visikol's Director of Drug Discovery, Peter Worthington Ph.D., to Present at SELECTBIO's 3D-Cell Culture, Organoids, and Organs-on-Chips Conference [...]

Visikol to present at SELECTBIO’s December 2021 ConferenceCarol Tomaszewski2021-11-05T15:34:56-05:00

HUREL Models Assist in the Evaluation of Hepatoxicity

Carol Tomaszewski2021-10-25T09:07:40-05:00

Many drug candidates fail during clinical trials and post-market withdrawal due to hepatoxicity or Drug Induced Liver Injury (DILI). [...]

HUREL Models Assist in the Evaluation of HepatoxicityCarol Tomaszewski2021-10-25T09:07:40-05:00

This website uses cookies to enhance the user experience. Ok